Pharmaceutical Gelatin Market by Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry), Application (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat), Function (Stabilizing, Thickening, Gelling), Region - Global Forecast to 2025
The global pharmaceutical gelatin market is projected to reach USD 1.2 billion by 2025 from USD
1.0 billion in 2020, at a CAGR of 5.3% during the forecast period. Growth in this market is driven by the advantages of pharmaceutical gelatin such as utility and versatility in medical and biomedical applications, unique functional properties, natural source of origin, and the increasing demand for pharmaceutical applications such as hard capsules and softgel capsules. However, factors such as cultural restrictions in consumption of porcine or bovine-derived gelatin, and rising prices of raw material are expected to restrain the growth of this market to a certain extent during the forecast period.
“The hard capsules segment holds the highest market share, by application, in the forecast period.”
On the basis of application, the pharmaceutical gelatin market is segmented into hard capsules, softgel capsules, tablets, absorbable hemostats & other applications. The hard capsules segment is expected to hold the highest share in the pharmaceutical gelatin market during the forecast period. Growth in this segment is largely driven by the stability, safety, security and efficacy provided by gelatin in hard capsules, and suitability of gelatin hard capsules for immediate-release dosing.
“Increasing preference for bovine bone as an alternative to pig meat gelatin in the pharmaceutical industry driving market growth for this segment.”
On the basis of source, the pharmaceutical gelatin market is further segmented into porcine, bovine skin, bovine bone, marine & poultry. The bovine bone segment is projected to witness the highest growth in the pharmaceutical gelatin market, by source, during the forecast period. Bovine bone is suitable for use across a range of pharmaceutical applications including hard and softgel capsules, tablets, gelatin sponges, and plasma expanders due to its low Bloom and high viscosity. The high viscosity to Bloom ratio of bovine bone is especially advantageous in the manufacture of softgel capsules. These factors are accelerating the growth of this segment during the forecast period.
“By function, the stabilizing agent segment holds the highest market share in the pharmaceutical gelatin market”
On the basis of function, the pharmaceutical gelatin market is further segmented into stabilizing agent, thickening agent, gelling agent & other functions. The stabilizing agent segment is expected to hold the highest share in the pharmaceutical gelatin market, by source, during the forecast period. Gelatin has the ability to reduce surface and interfacial tensions, adsorb on to solid surfaces, and enhance the stability of oil-in-water emulsions, moreover, film formation by gelatin can stabilize surface interfaces by forming a film. These effects are utilized in the stabilization of emulsions in pharmaceutical applications and can be attributed to the large market share of this segment during the forecast period.
“By type, Type A pharmaceutical gelatin is growing at the fastest rate in the forecast period”
On the basis of type, the pharmaceutical gelatin market is further segmented into Type A and Type B. The Type A segment relates mainly to porcine gelatin. The Type A process for porcine gelatin requires shorter time for pre-treatment prior to the extraction of gelatin and minimizes the generation of waste water. These factors are projected to drive the growth of the Type A segment during the forecast period.
“North American region holds the highest market share in the pharmaceutical gelatin market”
North America is expected to account for the largest share of the global pharmaceutical gelatin market in 2019. The large share of the North American region is due to the demand for gelatin for applications in the pharmaceutical industry, easy availability of raw material in the region and business presence of a large number of market players in the region.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage:
The report analyzes the market for various pharmaceutical gelatin market and their adoption pattern. It aims at estimating the market size and future growth potential of the global pharmaceutical gelatin market and different segments such as application, source, type, function and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.
This report provides insights on the following pointers:
1.0 billion in 2020, at a CAGR of 5.3% during the forecast period. Growth in this market is driven by the advantages of pharmaceutical gelatin such as utility and versatility in medical and biomedical applications, unique functional properties, natural source of origin, and the increasing demand for pharmaceutical applications such as hard capsules and softgel capsules. However, factors such as cultural restrictions in consumption of porcine or bovine-derived gelatin, and rising prices of raw material are expected to restrain the growth of this market to a certain extent during the forecast period.
“The hard capsules segment holds the highest market share, by application, in the forecast period.”
On the basis of application, the pharmaceutical gelatin market is segmented into hard capsules, softgel capsules, tablets, absorbable hemostats & other applications. The hard capsules segment is expected to hold the highest share in the pharmaceutical gelatin market during the forecast period. Growth in this segment is largely driven by the stability, safety, security and efficacy provided by gelatin in hard capsules, and suitability of gelatin hard capsules for immediate-release dosing.
“Increasing preference for bovine bone as an alternative to pig meat gelatin in the pharmaceutical industry driving market growth for this segment.”
On the basis of source, the pharmaceutical gelatin market is further segmented into porcine, bovine skin, bovine bone, marine & poultry. The bovine bone segment is projected to witness the highest growth in the pharmaceutical gelatin market, by source, during the forecast period. Bovine bone is suitable for use across a range of pharmaceutical applications including hard and softgel capsules, tablets, gelatin sponges, and plasma expanders due to its low Bloom and high viscosity. The high viscosity to Bloom ratio of bovine bone is especially advantageous in the manufacture of softgel capsules. These factors are accelerating the growth of this segment during the forecast period.
“By function, the stabilizing agent segment holds the highest market share in the pharmaceutical gelatin market”
On the basis of function, the pharmaceutical gelatin market is further segmented into stabilizing agent, thickening agent, gelling agent & other functions. The stabilizing agent segment is expected to hold the highest share in the pharmaceutical gelatin market, by source, during the forecast period. Gelatin has the ability to reduce surface and interfacial tensions, adsorb on to solid surfaces, and enhance the stability of oil-in-water emulsions, moreover, film formation by gelatin can stabilize surface interfaces by forming a film. These effects are utilized in the stabilization of emulsions in pharmaceutical applications and can be attributed to the large market share of this segment during the forecast period.
“By type, Type A pharmaceutical gelatin is growing at the fastest rate in the forecast period”
On the basis of type, the pharmaceutical gelatin market is further segmented into Type A and Type B. The Type A segment relates mainly to porcine gelatin. The Type A process for porcine gelatin requires shorter time for pre-treatment prior to the extraction of gelatin and minimizes the generation of waste water. These factors are projected to drive the growth of the Type A segment during the forecast period.
“North American region holds the highest market share in the pharmaceutical gelatin market”
North America is expected to account for the largest share of the global pharmaceutical gelatin market in 2019. The large share of the North American region is due to the demand for gelatin for applications in the pharmaceutical industry, easy availability of raw material in the region and business presence of a large number of market players in the region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–36%, Tier 2–39%, and Tier 3–25%
- By Designation: C-level–23%, Director Level–36%, and Others–41%
- By Region: North America–40%, Europe–15%, Asia Pacific–29%, Latin America- 8%, Middle East & Africa – 8%
Research Coverage:
The report analyzes the market for various pharmaceutical gelatin market and their adoption pattern. It aims at estimating the market size and future growth potential of the global pharmaceutical gelatin market and different segments such as application, source, type, function and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global pharmaceutical gelatin market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the global pharmaceutical gelatin market
- Market Development: Comprehensive information on the lucrative emerging regions by products, end user, and region
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global pharmaceutical gelatin market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of leading players in the global pharmaceutical gelatin market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE PHARMACEUTICAL GELATIN MARKET
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.4.1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.3 PRIMARY SOURCES
2.1.3.1 Key data from primary sources
2.1.3.2 Breakdown of Primaries
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019)
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019)
FIGURE 5 SUPPLY SIDE ANALYSIS: PHARMACEUTICAL GELATIN MARKET (2019)
FIGURE 6 APPROACH 3: BASED ON SOURCE, BY REGION (2019)
FIGURE 7 APPROACH 4: BASED ON RAW MATERIAL UTILIZATION IN GELATIN EMPTY CAPSULES
FIGURE 8 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE PHARMACEUTICAL GELATIN MARKET (2020-2025)
2.3 DATA TRIANGULATION APPROACH
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 COVID-19 HEALTH ASSESSMENT
2.7 COVID-19 ECONOMIC ASSESSMENT
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 11 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 12 SCENARIOS OF THE RECOVERY OF THE GLOBAL ECONOMY
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO PERTAINING TO THE PHARMACEUTICAL GELATIN MARKET
3 EXECUTIVE SUMMARY
FIGURE 13 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 14 PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020 VS. 2025 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE PHARMACEUTICAL GELATIN MARKET
4 PREMIUM INSIGHTS
4.1 PHARMACEUTICAL GELATIN MARKET OVERVIEW
FIGURE 16 VERSATILITY OF GELATIN IN PHARMACEUTICAL AND BIOMEDICAL APPLICATIONS DRIVING MARKET GROWTH
4.2 PHARMACEUTICAL GELATIN MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 INDIA PROJECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
4.3 REGIONAL MIX: PHARMACEUTICAL GELATIN MARKET (2020–2025)
FIGURE 18 ASIA PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD (2020–2025)
4.4 PHARMACEUTICAL GELATIN MARKET: DEVELOPED VS. EMERGING MARKETS, 2020 VS. 2025 (USD MILLION)
FIGURE 19 EMERGING MARKETS TO GROW AT HIGHER CAGRS DURING THE STUDY PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 PHARMACEUTICAL GELATIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Versatility and superiority of gelatin in pharmaceutical applications
FIGURE 21 MEAN PERCENTAGE OF RIBOFLAVIN RELEASED FROM GELATIN, HPMC
(1ST GENERATION), AND PULLULAN CAPSULES IN 0.1 M HCL BUFFER
5.2.1.2 Gelatin is an all-natural product fulfilling pharmaceutical regulations
5.2.2 RESTRAINTS
5.2.2.1 Increasing popularity of veganism
FIGURE 22 UK: RISING TREND OF VEGANISM FROM 2014 TO 2019 (‘000)
5.2.2.2 Cultural restrictions limit the growth of pharmaceutical gelatin in certain regions
5.2.3 OPPORTUNITIES
5.2.3.1 Rising demand for pharmaceutical-grade gelatin in emerging countries
5.2.3.2 Enhancements in the properties of gelatin broaden the scope of its pharmaceutical applications
5.2.4 CHALLENGES
5.2.4.1 Increasing incidences of animal-borne diseases
FIGURE 23 CHINA: PORK IMPORTS (2018-2020)
FIGURE 24 CHINA: PER CAPITA PORK AVAILABILITY PER PERSON (2018-2020)
5.2.4.2 Rising prices and poor availability of raw materials
5.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 1 PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 COMPETITIVE RIVALRY
5.4 TRENDS IN AVERAGE SELLING PRICE
TABLE 2 AVERAGE SELLING PRICE OF PHARMACEUTICAL GELATIN, BY REGION, 2019-2020
5.5 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS: PHARMACEUTICAL GELATIN MARKET
5.5.1 SOURCING OF RAW MATERIAL
5.5.2 COLLECTION AND TRANSPORT OF RAW MATERIAL
5.5.3 RAW MATERIAL PREPARATION AND PROCESSING
5.5.4 GELATIN PRODUCTION
5.5.5 DISTRIBUTION TO END USERS
5.6 ECOSYSTEM MAP
FIGURE 26 ECOSYSTEM: PHARMACEUTICAL GELATIN MARKET
5.6.1 INTRODUCTION
5.6.2 FARMING INPUT
5.6.3 FARMING
5.6.4 SLAUGHTERING
5.6.5 MANUFACTURING
5.6.6 SUPPLIERS/DISTRIBUTORS
5.6.7 END-PRODUCT MANUFACTURERS
5.7 KEY MARKETS FOR IMPORT/EXPORT
5.7.1 US
5.7.2 CHINA
5.7.3 BRAZIL
TABLE 3 IMPORTS & EXPORTS OF GELATIN, BY COUNTRY: (2018/2019)
UNITS – 1,000 TONS
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 PRODUCT INNOVATIONS OVERCOME CROSSLINKING OF GELATIN
6.2.2 INCREASING BIOMEDICAL APPLICATIONS OF GELATIN
6.2.3 INSIGHTS ON THE CONVERSION OF GELATIN TO COLLAGEN PEPTIDE AND PHARMACEUTICAL GELATIN
6.3 IMPACT OF THE COLLAGEN PEPTIDES MARKET ON PHARMACEUTICAL GELATIN
6.4 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET
6.5 REGULATORY ANALYSIS
7 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 4 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
7.2 HARD CAPSULES
7.2.1 COST-EFFECTIVITY OF GELATIN HARD CAPSULES DRIVES THE GROWTH OF THIS SEGMENT
TABLE 5 TYPICAL HARD GELATIN CAPSULE COMPOSITION
TABLE 6 DIMENSIONS (IN MILLIMETERS) OF TWO-PIECE HARD CAPSULES
TABLE 7 HARD CAPSULES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.3 SOFTGEL CAPSULES
7.3.1 RISING APPLICATIONS OF SOFTGEL CAPSULES INCREASE THEIR DEMAND IN THE PHARMACEUTICAL GELATIN MARKET
TABLE 8 DIFFERENCES BETWEEN HARD CAPSULES AND SOFTGEL CAPSULES
TABLE 9 SOFTGEL CAPSULES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.4 TABLETS
7.4.1 THE APPLICATION OF GELATIN IN TABLET BINDING AND COATING IS EXPECTED TO INCREASE DURING THE FORECAST PERIOD
TABLE 10 IN VITRO PROPERTIES OF TABLET WITH GELATIN AS BINDER (CONCENTRATIONS 2.0-8.0%)
TABLE 11 TABLETS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.5 ABSORBABLE HEMOSTATS
7.5.1 INCREASING APPLICATIONS OF GELATIN IN ABSORBABLE HEMOSTATS DUE TO BIOCOMPATIBILITY TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 12 ABSORBABLE HEMOSTATS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.6 OTHER APPLICATIONS
7.6.1 VERSATILITY OF GELATIN DUE TO ITS UNIQUE FUNCTIONAL PROPERTIES BOOSTS ITS SCOPE FOR APPLICATIONS ACROSS THE PHARMACEUTICAL INDUSTRY
TABLE 13 OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
7.7 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET, BY APPLICATION
8 PHARMACEUTICAL GELATIN MARKET, BY SOURCE
8.1 INTRODUCTION
8.1.1 GELATIN: REGULATIONS IMPLEMENTED BY DIFFERENT REGIONS/COUNTRIES
TABLE 14 PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 15 PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2025 (KT)
8.2 PORCINE
8.2.1 LOWER MANUFACTURING COSTS OF PORCINE RAW MATERIAL TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 16 US: PORK EXPORTS IN USD MILLION (2019)
TABLE 17 PORCINE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 18 PORCINE MARKET, BY REGION, 2018–2025 (KT)
8.3 BOVINE SKIN
8.3.1 INCREASING AVAILABILITY OF BOVINE SKIN TO BOOST APPLICATION IN THE PHARMACEUTICAL GELATIN MARKET
TABLE 19 US: EXPORT STATISTICS FOR BOVINE FRESH/WET SALTED HIDES
(NUMBER OF PIECES)
TABLE 20 US: EXPORT STATISTICS FOR BOVINE FRESH/WET SALTED HIDES
(VALUE IN USD THOUSAND)
TABLE 21 BOVINE SKIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 BOVINE SKIN MARKET, BY REGION, 2018–2025 (KT)
8.4 BOVINE BONE
8.4.1 RISING PREFERENCE FOR BOVINE BONE AS RAW MATERIAL IN THE PHARMACEUTICAL GELATIN MARKET DUE TO LOW BLOOM AND HIGH VISCOSITY
TABLE 23 BOVINE BONE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 BOVINE BONE MARKET, BY REGION, 2018–2025 (KT)
8.5 MARINE
8.5.1 RISING INCIDENCE OF ZOONOTIC DISEASES IN CATTLE AND PIGS TO DRIVE THE GROWTH OF MARINE SOURCE IN THE PHARMACEUTICAL GELATIN MARKET
TABLE 25 MARINE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 26 MARINE MARKET, BY REGION, 2018–2025 (KT)
8.6 POULTRY
8.6.1 STEADY AVAILABILITY OF POULTRY AS RAW MATERIAL IS EXPECTED TO BOOST UTILITY AS RAW MATERIAL IN THE PHARMACEUTICAL GELATIN MARKET
TABLE 27 AMINO ACID COMPOSITION OF GELATIN FROM DIFFERENT SOURCES
TABLE 28 POULTRY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 29 POULTRY MARKET, BY REGION, 2018–2025 (KT)
8.7 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET, BY SOURCE
FIGURE 27 BEEF EXPORTS FROM BRAZIL (1,000 TONS)
9 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION
9.1 INTRODUCTION
FIGURE 28 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION
9.2 BLOOM VALUE
9.2.1 HIGH BLOOM
9.2.2 LOW BLOOM
TABLE 30 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2025 (USD MILLION)
9.3 STABILIZING AGENTS
9.3.1 THE HIGH SHARE OF GELATIN IN THIS SEGMENT CAN BE ATTRIBUTED TO UTILITY AS A STABILIZING AGENT FOR CAPSULES AND VACCINES
TABLE 31 STABILIZING AGENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
9.4 THICKENING AGENTS
9.4.1 THE RISING USE OF SYRUPS AND LIQUID DOSAGE FORMS TO DRIVE THE GROWTH OF THIS FUNCTIONAL SEGMENT IN THE PHARMACEUTICAL GELATIN MARKET
FIGURE 29 VISCOSITY BEHAVIOR OF GELATIN AS A FUNCTION OF TEMPERATURE AT 60OC
TABLE 32 THICKENING AGENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
9.5 GELLING AGENTS & OTHER FUNCTIONS
9.5.1 THE UNIQUE GELLING PROPERTY OF GELATIN FINDS A SIGNIFICANT NUMBER OF APPLICATIONS IN THE FORMATION OF SOFTGEL CAPSULES AND HEMOSTATS
TABLE 33 GELLING AGENTS & OTHER FUNCTIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
10 PHARMACEUTICAL GELATIN MARKET, BY TYPE
10.1 INTRODUCTION
FIGURE 30 PRODUCTION PROCESS: TYPE A AND TYPE B GELATIN
TABLE 34 SPECIFICATIONS FOR PHARMACEUTICAL-GRADE GELATIN: HARD CAPSULES
TABLE 35 SPECIFICATIONS FOR PHARMACEUTICAL-GRADE GELATIN: SOFTGEL CAPSULES
TABLE 36 SPECIFICATIONS FOR PHARMACEUTICAL-GRADE GELATIN: TABLET GELATIN
TABLE 37 PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.2 TYPE B
10.2.1 THE RISING DEMAND FOR BOVINE SOURCE RAW MATERIAL PROJECTED TO DRIVE THE GROWTH OF TYPE B GELATIN DURING THE FORECAST PERIOD
TABLE 38 NUTRITIONAL COMPOSITION OF TYPE B GELATIN
TABLE 39 TYPE B GELATIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
10.3 TYPE A
10.3.1 COST-EFFECTIVENESS OF PROCESSING TYPE A GELATIN IS FAVORING GROWTH IN THE MARKET
TABLE 40 NUTRITIONAL COMPOSITION OF TYPE A GELATIN
TABLE 41 TYPE A GELATIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
11 PHARMACEUTICAL GELATIN MARKET, BY REGION
11.1 INTRODUCTION
FIGURE 31 INDIA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD IN THE PHARMACEUTICAL GELATIN MARKET (IN TERMS OF VALUE)
TABLE 42 PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 43 PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2025 (KT)
11.2 NORTH AMERICA
11.2.1 THE LARGE MARKET SHARE OF THE NORTH AMERICAN REGION CAN BE ATTRIBUTED TO THE HIGH R&D INVESTMENTS
FIGURE 32 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SNAPSHOT
TABLE 44 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 45 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 46 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 47 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 48 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.2.2 US
11.2.2.1 Rising concerns in arthritis and obesity to drive the gelatin market in the US
TABLE 49 US: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 50 US: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 51 US: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 52 US: PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.2.3 CANADA
11.2.3.1 Rising domestic demand for pharmaceutical products to drive the growth of the pharmaceutical gelatin market
TABLE 53 CANADA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 54 CANADA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 55 CANADA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 56 CANADA: PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.3 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN NORTH AMERICA
11.4 EUROPE
11.4.1 RELIABLE AVAILABILITY OF RAW MATERIAL AND RISING DEMAND FOR MEDICATION IS DRIVING THE GROWTH OF THE PHARMACEUTICAL GELATIN MARKET IN THE EUROPEAN REGION
FIGURE 33 EUROPE: PHARMACEUTICAL GELATIN MARKET SNAPSHOT
TABLE 57 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 58 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 59 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 60 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 61 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION)
11.4.2 GERMANY
11.4.2.1 Growth of the pharmaceutical industry in Germany to drive the demand for gelatin
TABLE 62 GERMANY: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 63 GERMANY: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 64 GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 65 GERMANY: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION)
11.4.3 FRANCE
11.4.3.1 High beef production in France to drive the pharmaceutical gelatin market
TABLE 66 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 67 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 68 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 69 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION)
11.4.4 UK
11.4.4.1 Higher healthcare spending and medicine consumption fuels pharmaceutical gelatin market growth
TABLE 70 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 71 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 72 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 73 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION)
11.4.5 ITALY
11.4.5.1 Growth of the pharmaceutical manufacturing industry to fuel the demand for gelatin
TABLE 74 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 75 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 76 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 77 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION)
11.4.6 SPAIN
11.4.6.1 Abundance of porcine raw material to drive the market for gelatin in Spain
TABLE 78 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 79 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 80 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 81 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION)
11.4.7 REST OF EUROPE
11.4.7.1 High consumption and production to drive the growth of the pharmaceutical gelatin market in Rest of Europe
TABLE 82 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 83 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 84 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 85 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION)
11.5 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN EUROPE
11.6 ASIA PACIFIC
11.6.1 INCREASE IN CHRONIC ILLNESSES AND DEMAND FOR MEDICATION BOOSTS THE GROWTH OF THE PHARMACEUTICAL GELATIN MARKET
FIGURE 34 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SNAPSHOT
TABLE 86 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 87 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 2018–2025 (USD MILLION)
TABLE 88 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 89 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 90 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.6.2 CHINA
11.6.2.1 China’s large population and rise in chronic diseases drive the market for gelatin
TABLE 91 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION
2018–2025 (USD MILLION)
TABLE 92 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 93 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 94 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.6.3 JAPAN
11.6.3.1 Increasing aging population drives the market for pharmaceutical gelatin
TABLE 95 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION
2018–2025 (USD MILLION)
TABLE 96 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 97 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 98 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.6.4 INDIA
11.6.4.1 The booming pharmaceutical industry in the country propels the growth of the pharmaceutical gelatin market
TABLE 99 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION
2018–2025 (USD MILLION)
TABLE 100 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 101 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 102 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.6.5 REST OF ASIA PACIFIC
11.6.5.1 Australian and Vietnamese pharmaceutical industries drive the demand for pharmaceutical gelatin
TABLE 103 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 2018–2025 (USD MILLION)
TABLE 104 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 105 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 106 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.7 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN THE ASIA PACIFIC REGION
11.8 REST OF THE WORLD
TABLE 107 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION 2018–2025 (USD MILLION)
TABLE 108 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 2018–2025 (USD MILLION)
TABLE 109 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 110 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 111 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.8.1 LATIN AMERICA
11.8.1.1 High availability of raw material drives the growth of the pharmaceutical gelatin market in Latin America
TABLE 112 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 2018–2025 (USD MILLION)
TABLE 113 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 114 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 115 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.8.2 MIDDLE EAST & AFRICA
11.8.2.1 Rising popularity of halal gelatin drives the growth of the pharmaceutical gelatin market in the Middle East
TABLE 116 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 2018–2025 (USD MILLION)
TABLE 117 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 118 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 119 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.9 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN THE REST OF THE WORLD
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
FIGURE 35 KEY DEVELOPMENTS IN THE GLOBAL PHARMACEUTICAL GELATIN MARKET, 2017–2020
FIGURE 36 MARKET EVALUATION FRAMEWORK: EXPANSIONS DOMINATED THE MARKET IN 2018 AND 2019
12.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
12.3 PRODUCT BENCHMARKING
12.4 PHARMACEUTICAL GELATIN MARKET: GEOGRAPHICAL ASSESSMENT
12.5 COMPETITIVE SITUATIONS AND TRENDS
TABLE 120 PRODUCT LAUNCHES (2018-2020)
TABLE 121 EXPANSIONS (2018–2019)
TABLE 122 ACQUISITIONS (2018)
TABLE 123 AGREEMENTS (2017)
TABLE 124 OTHER DEVELOPMENTS (2020)
13 COMPANY EVALUATION MATRIX AND COMPANY PROFILES
13.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY
13.2 PHARMACEUTICAL GELATIN MARKET SHARE
FIGURE 39 PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYERS (2019)
13.3 COMPETITIVE LEADERSHIP MAPPING
13.3.1 STARS
13.3.2 EMERGING LEADERS
13.3.3 PERVASIVE
13.3.4 EMERGING COMPANIES
FIGURE 40 PHARMACEUTICAL GELATIN MARKET: COMPANY EVALUATION MATRIX, 2019
13.4 COMPANY PROFILES
(Business and financial overview, Products offered, Recent developments, SWOT analysis, and MNM view)
13.4.1 DARLING INGREDIENTS INC.
FIGURE 41 DARLING INGREDIENTS INC.: COMPANY SNAPSHOT (2019)
13.4.2 NITTA GELATIN INC.
FIGURE 42 NITTA GELATIN INC: COMPANY SNAPSHOT (2020)
13.4.3 TESSENDERLO GROUP
FIGURE 43 TESSENDERLO GROUP: COMPANY SNAPSHOT (2019)
13.4.4 GELITA AG
13.4.5 WEISHARDT
13.4.6 TROBAS GELATINE B.V.
13.4.7 LAPI GELATINE S.P.A
13.4.8 INDIA GELATINE & CHEMICALS LTD.
FIGURE 44 INDIA GELATINE & CHEMICALS LTD.: COMPANY SNAPSHOT (2020)
13.4.9 GELNEX INDUSTRIA E COMERCIO LTDA
13.4.10 JUNCA GELATINES SL
13.4.11 ITALGELATINE S.P.A.
13.4.12 XIAMEN GELKEN GELATIN CO. LTD.
13.4.13 GELCO INTERNATIONAL
13.4.14 HENAN BOOM GELATIN CO. LTD.
13.4.15 BAOTOU DONGBAO BIO-TECH CO. LTD.
FIGURE 45 BAOTOU DONGBAO BIO-TECH CO. LTD: COMPANY SNAPSHOT (2019)
13.4.16 ASPIRE PHARMACEUTICALS
13.4.17 NORLAND PRODUCTS, INC.
13.4.18 GELTECH CO. LTD.
13.4.19 GELIKO LLC
13.4.20 KENNEY & ROSS LIMITED
*Details on Business and financial overview, Products offered, Recent developments, SWOT analysis, and MNM view might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RELATED REPORTS
14.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE PHARMACEUTICAL GELATIN MARKET
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.4.1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.3 PRIMARY SOURCES
2.1.3.1 Key data from primary sources
2.1.3.2 Breakdown of Primaries
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019)
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019)
FIGURE 5 SUPPLY SIDE ANALYSIS: PHARMACEUTICAL GELATIN MARKET (2019)
FIGURE 6 APPROACH 3: BASED ON SOURCE, BY REGION (2019)
FIGURE 7 APPROACH 4: BASED ON RAW MATERIAL UTILIZATION IN GELATIN EMPTY CAPSULES
FIGURE 8 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE PHARMACEUTICAL GELATIN MARKET (2020-2025)
2.3 DATA TRIANGULATION APPROACH
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 COVID-19 HEALTH ASSESSMENT
2.7 COVID-19 ECONOMIC ASSESSMENT
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 11 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 12 SCENARIOS OF THE RECOVERY OF THE GLOBAL ECONOMY
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO PERTAINING TO THE PHARMACEUTICAL GELATIN MARKET
3 EXECUTIVE SUMMARY
FIGURE 13 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 14 PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020 VS. 2025 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE PHARMACEUTICAL GELATIN MARKET
4 PREMIUM INSIGHTS
4.1 PHARMACEUTICAL GELATIN MARKET OVERVIEW
FIGURE 16 VERSATILITY OF GELATIN IN PHARMACEUTICAL AND BIOMEDICAL APPLICATIONS DRIVING MARKET GROWTH
4.2 PHARMACEUTICAL GELATIN MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 INDIA PROJECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
4.3 REGIONAL MIX: PHARMACEUTICAL GELATIN MARKET (2020–2025)
FIGURE 18 ASIA PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD (2020–2025)
4.4 PHARMACEUTICAL GELATIN MARKET: DEVELOPED VS. EMERGING MARKETS, 2020 VS. 2025 (USD MILLION)
FIGURE 19 EMERGING MARKETS TO GROW AT HIGHER CAGRS DURING THE STUDY PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 PHARMACEUTICAL GELATIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Versatility and superiority of gelatin in pharmaceutical applications
FIGURE 21 MEAN PERCENTAGE OF RIBOFLAVIN RELEASED FROM GELATIN, HPMC
(1ST GENERATION), AND PULLULAN CAPSULES IN 0.1 M HCL BUFFER
5.2.1.2 Gelatin is an all-natural product fulfilling pharmaceutical regulations
5.2.2 RESTRAINTS
5.2.2.1 Increasing popularity of veganism
FIGURE 22 UK: RISING TREND OF VEGANISM FROM 2014 TO 2019 (‘000)
5.2.2.2 Cultural restrictions limit the growth of pharmaceutical gelatin in certain regions
5.2.3 OPPORTUNITIES
5.2.3.1 Rising demand for pharmaceutical-grade gelatin in emerging countries
5.2.3.2 Enhancements in the properties of gelatin broaden the scope of its pharmaceutical applications
5.2.4 CHALLENGES
5.2.4.1 Increasing incidences of animal-borne diseases
FIGURE 23 CHINA: PORK IMPORTS (2018-2020)
FIGURE 24 CHINA: PER CAPITA PORK AVAILABILITY PER PERSON (2018-2020)
5.2.4.2 Rising prices and poor availability of raw materials
5.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 1 PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 COMPETITIVE RIVALRY
5.4 TRENDS IN AVERAGE SELLING PRICE
TABLE 2 AVERAGE SELLING PRICE OF PHARMACEUTICAL GELATIN, BY REGION, 2019-2020
5.5 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS: PHARMACEUTICAL GELATIN MARKET
5.5.1 SOURCING OF RAW MATERIAL
5.5.2 COLLECTION AND TRANSPORT OF RAW MATERIAL
5.5.3 RAW MATERIAL PREPARATION AND PROCESSING
5.5.4 GELATIN PRODUCTION
5.5.5 DISTRIBUTION TO END USERS
5.6 ECOSYSTEM MAP
FIGURE 26 ECOSYSTEM: PHARMACEUTICAL GELATIN MARKET
5.6.1 INTRODUCTION
5.6.2 FARMING INPUT
5.6.3 FARMING
5.6.4 SLAUGHTERING
5.6.5 MANUFACTURING
5.6.6 SUPPLIERS/DISTRIBUTORS
5.6.7 END-PRODUCT MANUFACTURERS
5.7 KEY MARKETS FOR IMPORT/EXPORT
5.7.1 US
5.7.2 CHINA
5.7.3 BRAZIL
TABLE 3 IMPORTS & EXPORTS OF GELATIN, BY COUNTRY: (2018/2019)
UNITS – 1,000 TONS
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 PRODUCT INNOVATIONS OVERCOME CROSSLINKING OF GELATIN
6.2.2 INCREASING BIOMEDICAL APPLICATIONS OF GELATIN
6.2.3 INSIGHTS ON THE CONVERSION OF GELATIN TO COLLAGEN PEPTIDE AND PHARMACEUTICAL GELATIN
6.3 IMPACT OF THE COLLAGEN PEPTIDES MARKET ON PHARMACEUTICAL GELATIN
6.4 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET
6.5 REGULATORY ANALYSIS
7 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 4 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
7.2 HARD CAPSULES
7.2.1 COST-EFFECTIVITY OF GELATIN HARD CAPSULES DRIVES THE GROWTH OF THIS SEGMENT
TABLE 5 TYPICAL HARD GELATIN CAPSULE COMPOSITION
TABLE 6 DIMENSIONS (IN MILLIMETERS) OF TWO-PIECE HARD CAPSULES
TABLE 7 HARD CAPSULES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.3 SOFTGEL CAPSULES
7.3.1 RISING APPLICATIONS OF SOFTGEL CAPSULES INCREASE THEIR DEMAND IN THE PHARMACEUTICAL GELATIN MARKET
TABLE 8 DIFFERENCES BETWEEN HARD CAPSULES AND SOFTGEL CAPSULES
TABLE 9 SOFTGEL CAPSULES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.4 TABLETS
7.4.1 THE APPLICATION OF GELATIN IN TABLET BINDING AND COATING IS EXPECTED TO INCREASE DURING THE FORECAST PERIOD
TABLE 10 IN VITRO PROPERTIES OF TABLET WITH GELATIN AS BINDER (CONCENTRATIONS 2.0-8.0%)
TABLE 11 TABLETS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.5 ABSORBABLE HEMOSTATS
7.5.1 INCREASING APPLICATIONS OF GELATIN IN ABSORBABLE HEMOSTATS DUE TO BIOCOMPATIBILITY TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 12 ABSORBABLE HEMOSTATS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.6 OTHER APPLICATIONS
7.6.1 VERSATILITY OF GELATIN DUE TO ITS UNIQUE FUNCTIONAL PROPERTIES BOOSTS ITS SCOPE FOR APPLICATIONS ACROSS THE PHARMACEUTICAL INDUSTRY
TABLE 13 OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
7.7 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET, BY APPLICATION
8 PHARMACEUTICAL GELATIN MARKET, BY SOURCE
8.1 INTRODUCTION
8.1.1 GELATIN: REGULATIONS IMPLEMENTED BY DIFFERENT REGIONS/COUNTRIES
TABLE 14 PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 15 PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2025 (KT)
8.2 PORCINE
8.2.1 LOWER MANUFACTURING COSTS OF PORCINE RAW MATERIAL TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 16 US: PORK EXPORTS IN USD MILLION (2019)
TABLE 17 PORCINE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 18 PORCINE MARKET, BY REGION, 2018–2025 (KT)
8.3 BOVINE SKIN
8.3.1 INCREASING AVAILABILITY OF BOVINE SKIN TO BOOST APPLICATION IN THE PHARMACEUTICAL GELATIN MARKET
TABLE 19 US: EXPORT STATISTICS FOR BOVINE FRESH/WET SALTED HIDES
(NUMBER OF PIECES)
TABLE 20 US: EXPORT STATISTICS FOR BOVINE FRESH/WET SALTED HIDES
(VALUE IN USD THOUSAND)
TABLE 21 BOVINE SKIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 BOVINE SKIN MARKET, BY REGION, 2018–2025 (KT)
8.4 BOVINE BONE
8.4.1 RISING PREFERENCE FOR BOVINE BONE AS RAW MATERIAL IN THE PHARMACEUTICAL GELATIN MARKET DUE TO LOW BLOOM AND HIGH VISCOSITY
TABLE 23 BOVINE BONE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 BOVINE BONE MARKET, BY REGION, 2018–2025 (KT)
8.5 MARINE
8.5.1 RISING INCIDENCE OF ZOONOTIC DISEASES IN CATTLE AND PIGS TO DRIVE THE GROWTH OF MARINE SOURCE IN THE PHARMACEUTICAL GELATIN MARKET
TABLE 25 MARINE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 26 MARINE MARKET, BY REGION, 2018–2025 (KT)
8.6 POULTRY
8.6.1 STEADY AVAILABILITY OF POULTRY AS RAW MATERIAL IS EXPECTED TO BOOST UTILITY AS RAW MATERIAL IN THE PHARMACEUTICAL GELATIN MARKET
TABLE 27 AMINO ACID COMPOSITION OF GELATIN FROM DIFFERENT SOURCES
TABLE 28 POULTRY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 29 POULTRY MARKET, BY REGION, 2018–2025 (KT)
8.7 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET, BY SOURCE
FIGURE 27 BEEF EXPORTS FROM BRAZIL (1,000 TONS)
9 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION
9.1 INTRODUCTION
FIGURE 28 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION
9.2 BLOOM VALUE
9.2.1 HIGH BLOOM
9.2.2 LOW BLOOM
TABLE 30 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018–2025 (USD MILLION)
9.3 STABILIZING AGENTS
9.3.1 THE HIGH SHARE OF GELATIN IN THIS SEGMENT CAN BE ATTRIBUTED TO UTILITY AS A STABILIZING AGENT FOR CAPSULES AND VACCINES
TABLE 31 STABILIZING AGENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
9.4 THICKENING AGENTS
9.4.1 THE RISING USE OF SYRUPS AND LIQUID DOSAGE FORMS TO DRIVE THE GROWTH OF THIS FUNCTIONAL SEGMENT IN THE PHARMACEUTICAL GELATIN MARKET
FIGURE 29 VISCOSITY BEHAVIOR OF GELATIN AS A FUNCTION OF TEMPERATURE AT 60OC
TABLE 32 THICKENING AGENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
9.5 GELLING AGENTS & OTHER FUNCTIONS
9.5.1 THE UNIQUE GELLING PROPERTY OF GELATIN FINDS A SIGNIFICANT NUMBER OF APPLICATIONS IN THE FORMATION OF SOFTGEL CAPSULES AND HEMOSTATS
TABLE 33 GELLING AGENTS & OTHER FUNCTIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
10 PHARMACEUTICAL GELATIN MARKET, BY TYPE
10.1 INTRODUCTION
FIGURE 30 PRODUCTION PROCESS: TYPE A AND TYPE B GELATIN
TABLE 34 SPECIFICATIONS FOR PHARMACEUTICAL-GRADE GELATIN: HARD CAPSULES
TABLE 35 SPECIFICATIONS FOR PHARMACEUTICAL-GRADE GELATIN: SOFTGEL CAPSULES
TABLE 36 SPECIFICATIONS FOR PHARMACEUTICAL-GRADE GELATIN: TABLET GELATIN
TABLE 37 PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
10.2 TYPE B
10.2.1 THE RISING DEMAND FOR BOVINE SOURCE RAW MATERIAL PROJECTED TO DRIVE THE GROWTH OF TYPE B GELATIN DURING THE FORECAST PERIOD
TABLE 38 NUTRITIONAL COMPOSITION OF TYPE B GELATIN
TABLE 39 TYPE B GELATIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
10.3 TYPE A
10.3.1 COST-EFFECTIVENESS OF PROCESSING TYPE A GELATIN IS FAVORING GROWTH IN THE MARKET
TABLE 40 NUTRITIONAL COMPOSITION OF TYPE A GELATIN
TABLE 41 TYPE A GELATIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
11 PHARMACEUTICAL GELATIN MARKET, BY REGION
11.1 INTRODUCTION
FIGURE 31 INDIA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD IN THE PHARMACEUTICAL GELATIN MARKET (IN TERMS OF VALUE)
TABLE 42 PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
TABLE 43 PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2025 (KT)
11.2 NORTH AMERICA
11.2.1 THE LARGE MARKET SHARE OF THE NORTH AMERICAN REGION CAN BE ATTRIBUTED TO THE HIGH R&D INVESTMENTS
FIGURE 32 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SNAPSHOT
TABLE 44 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 45 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 46 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 47 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 48 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.2.2 US
11.2.2.1 Rising concerns in arthritis and obesity to drive the gelatin market in the US
TABLE 49 US: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 50 US: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 51 US: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 52 US: PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.2.3 CANADA
11.2.3.1 Rising domestic demand for pharmaceutical products to drive the growth of the pharmaceutical gelatin market
TABLE 53 CANADA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 54 CANADA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 55 CANADA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 56 CANADA: PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.3 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN NORTH AMERICA
11.4 EUROPE
11.4.1 RELIABLE AVAILABILITY OF RAW MATERIAL AND RISING DEMAND FOR MEDICATION IS DRIVING THE GROWTH OF THE PHARMACEUTICAL GELATIN MARKET IN THE EUROPEAN REGION
FIGURE 33 EUROPE: PHARMACEUTICAL GELATIN MARKET SNAPSHOT
TABLE 57 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 58 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 59 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 60 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 61 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION)
11.4.2 GERMANY
11.4.2.1 Growth of the pharmaceutical industry in Germany to drive the demand for gelatin
TABLE 62 GERMANY: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 63 GERMANY: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 64 GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 65 GERMANY: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION)
11.4.3 FRANCE
11.4.3.1 High beef production in France to drive the pharmaceutical gelatin market
TABLE 66 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 67 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 68 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 69 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION)
11.4.4 UK
11.4.4.1 Higher healthcare spending and medicine consumption fuels pharmaceutical gelatin market growth
TABLE 70 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 71 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 72 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 73 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION)
11.4.5 ITALY
11.4.5.1 Growth of the pharmaceutical manufacturing industry to fuel the demand for gelatin
TABLE 74 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 75 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 76 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 77 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION)
11.4.6 SPAIN
11.4.6.1 Abundance of porcine raw material to drive the market for gelatin in Spain
TABLE 78 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 79 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 80 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 81 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION)
11.4.7 REST OF EUROPE
11.4.7.1 High consumption and production to drive the growth of the pharmaceutical gelatin market in Rest of Europe
TABLE 82 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 83 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 84 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 85 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION)
11.5 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN EUROPE
11.6 ASIA PACIFIC
11.6.1 INCREASE IN CHRONIC ILLNESSES AND DEMAND FOR MEDICATION BOOSTS THE GROWTH OF THE PHARMACEUTICAL GELATIN MARKET
FIGURE 34 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SNAPSHOT
TABLE 86 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 87 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 2018–2025 (USD MILLION)
TABLE 88 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 89 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 90 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.6.2 CHINA
11.6.2.1 China’s large population and rise in chronic diseases drive the market for gelatin
TABLE 91 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION
2018–2025 (USD MILLION)
TABLE 92 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 93 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 94 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.6.3 JAPAN
11.6.3.1 Increasing aging population drives the market for pharmaceutical gelatin
TABLE 95 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION
2018–2025 (USD MILLION)
TABLE 96 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 97 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 98 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.6.4 INDIA
11.6.4.1 The booming pharmaceutical industry in the country propels the growth of the pharmaceutical gelatin market
TABLE 99 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION
2018–2025 (USD MILLION)
TABLE 100 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 101 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 102 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.6.5 REST OF ASIA PACIFIC
11.6.5.1 Australian and Vietnamese pharmaceutical industries drive the demand for pharmaceutical gelatin
TABLE 103 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 2018–2025 (USD MILLION)
TABLE 104 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 105 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 106 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.7 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN THE ASIA PACIFIC REGION
11.8 REST OF THE WORLD
TABLE 107 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION 2018–2025 (USD MILLION)
TABLE 108 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 2018–2025 (USD MILLION)
TABLE 109 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 110 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 111 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.8.1 LATIN AMERICA
11.8.1.1 High availability of raw material drives the growth of the pharmaceutical gelatin market in Latin America
TABLE 112 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 2018–2025 (USD MILLION)
TABLE 113 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 114 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 115 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.8.2 MIDDLE EAST & AFRICA
11.8.2.1 Rising popularity of halal gelatin drives the growth of the pharmaceutical gelatin market in the Middle East
TABLE 116 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 2018–2025 (USD MILLION)
TABLE 117 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION)
TABLE 118 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION)
TABLE 119 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
11.9 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN THE REST OF THE WORLD
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
FIGURE 35 KEY DEVELOPMENTS IN THE GLOBAL PHARMACEUTICAL GELATIN MARKET, 2017–2020
FIGURE 36 MARKET EVALUATION FRAMEWORK: EXPANSIONS DOMINATED THE MARKET IN 2018 AND 2019
12.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
12.3 PRODUCT BENCHMARKING
12.4 PHARMACEUTICAL GELATIN MARKET: GEOGRAPHICAL ASSESSMENT
12.5 COMPETITIVE SITUATIONS AND TRENDS
TABLE 120 PRODUCT LAUNCHES (2018-2020)
TABLE 121 EXPANSIONS (2018–2019)
TABLE 122 ACQUISITIONS (2018)
TABLE 123 AGREEMENTS (2017)
TABLE 124 OTHER DEVELOPMENTS (2020)
13 COMPANY EVALUATION MATRIX AND COMPANY PROFILES
13.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY
13.2 PHARMACEUTICAL GELATIN MARKET SHARE
FIGURE 39 PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYERS (2019)
13.3 COMPETITIVE LEADERSHIP MAPPING
13.3.1 STARS
13.3.2 EMERGING LEADERS
13.3.3 PERVASIVE
13.3.4 EMERGING COMPANIES
FIGURE 40 PHARMACEUTICAL GELATIN MARKET: COMPANY EVALUATION MATRIX, 2019
13.4 COMPANY PROFILES
(Business and financial overview, Products offered, Recent developments, SWOT analysis, and MNM view)
13.4.1 DARLING INGREDIENTS INC.
FIGURE 41 DARLING INGREDIENTS INC.: COMPANY SNAPSHOT (2019)
13.4.2 NITTA GELATIN INC.
FIGURE 42 NITTA GELATIN INC: COMPANY SNAPSHOT (2020)
13.4.3 TESSENDERLO GROUP
FIGURE 43 TESSENDERLO GROUP: COMPANY SNAPSHOT (2019)
13.4.4 GELITA AG
13.4.5 WEISHARDT
13.4.6 TROBAS GELATINE B.V.
13.4.7 LAPI GELATINE S.P.A
13.4.8 INDIA GELATINE & CHEMICALS LTD.
FIGURE 44 INDIA GELATINE & CHEMICALS LTD.: COMPANY SNAPSHOT (2020)
13.4.9 GELNEX INDUSTRIA E COMERCIO LTDA
13.4.10 JUNCA GELATINES SL
13.4.11 ITALGELATINE S.P.A.
13.4.12 XIAMEN GELKEN GELATIN CO. LTD.
13.4.13 GELCO INTERNATIONAL
13.4.14 HENAN BOOM GELATIN CO. LTD.
13.4.15 BAOTOU DONGBAO BIO-TECH CO. LTD.
FIGURE 45 BAOTOU DONGBAO BIO-TECH CO. LTD: COMPANY SNAPSHOT (2019)
13.4.16 ASPIRE PHARMACEUTICALS
13.4.17 NORLAND PRODUCTS, INC.
13.4.18 GELTECH CO. LTD.
13.4.19 GELIKO LLC
13.4.20 KENNEY & ROSS LIMITED
*Details on Business and financial overview, Products offered, Recent developments, SWOT analysis, and MNM view might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RELATED REPORTS
14.6 AUTHOR DETAILS
